You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Muscle Invasive Bladder Cancer (NMIBC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

    Terminated
    • Non-muscle Invasive Bladder Cancer (NMIBC)
    • Hyaluronic Acid (HA) sodium salt and Hydeal-D
    • Rozzano, Mi, Italy
      Humanitas Research Hospital
    Sep 29, 2023

    Bladder Cancer Trial in Nara, Okayama (FE 999326)

    Recruiting
    • Bladder Cancer
    • FE 999326
    • Nara, Japan
    • +1 more
    Jan 19, 2023

    Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

    Active, not recruiting
    • Non-muscle-invasive Bladder Cancer
    • Gemcitabine 1000 mg, Docetaxel 37.5g
    • Zagreb, Croatia
      University Hospital Centre Zagreb
    Jan 20, 2023

    Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

    Recruiting
    • Urothelial Carcinoma
    • Non-Invasive Bladder Urothelial Carcinoma
    • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 2, 2023

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • Homewood, Alabama
    • +4 more
    Dec 15, 2022

    Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • Standard infusion chemotherapy
    • BL - 5 ala PDT
    • Xi'an, Shaanxi, China
      Dalin He
    Sep 19, 2022

    Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)

    Recruiting
    • Invasive Bladder Cancer
    • Madrid, Spain
      Hospital 12 de Octubre
    Feb 8, 2022

    Non-muscle-invasive Bladder Cancer Trial in Myrtle Beach, Nashville (AU-011, AU-011 in Combination with Medical Laser)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • AU-011
    • AU-011 in Combination with Medical Laser
    • Myrtle Beach, South Carolina
    • +1 more
    Jul 29, 2022

    Bladder Cancer Trial (pembrolizumab)

    Active, not recruiting
    • Bladder Cancer
    • Pembrolizumab
    • +2 more
    • (no location specified)
    Oct 11, 2022

    High-risk NMIBC Trial (SHR-1501)

    Recruiting
    • High-risk NMIBC
    • Beijing, Beijing, China
      Peking University First Hospital
    Nov 28, 2022

    Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • HER2
    • (no location specified)
    Jul 16, 2023

    Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

    Not yet recruiting
    • Non-Muscle- Invasive Bladder Cancer
    • Durvalumab
    • BCG
    • (no location specified)
    Jul 5, 2023

    Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202 in combination with Epirubicin, Placebo in combination with

    Active, not recruiting
    • Non-muscle Invasive Bladder Cancer
    • APL-1202 in combination with Epirubicin
    • Placebo in combination with Epirubicin
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Feb 21, 2022

    Bladder Cancer Trial in Athens (Durvalumab)

    Active, not recruiting
    • Bladder Cancer
    • Durvalumab
    • Athens, Attica, Greece
      Hellenic GenitoUrinary Cancer Group
    Mar 22, 2022

    Uromonitor asBiomarker for Optimization of NMIBC Management by

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      May 9, 2023

      Urine-based Molecular Testing vs Cystoscopy for Surveillance of

      Not yet recruiting
      • Non-muscle Invasive Bladder Cancer
      • +2 more
      • CxBladder Monitor
      • Cystoscopy
      • Scottsdale, Arizona
      • +2 more
      Nov 14, 2023

      Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

      Not yet recruiting
      • Bladder Cancer
      • +5 more
      • Bacillus Calmette-Guerin: Strain Russian BCG-I
      • Bacillus Calmette-Guerin: Strain TICE
      • (no location specified)
      Apr 7, 2022

      Urinary Bladder Tumors Trial in München (Catumaxomab)

      Recruiting
      • Urinary Bladder Neoplasms
      • München, Germany
        Urologie Planegg
      Apr 4, 2022

      Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

      Recruiting
      • Non-muscle Invasive Bladder Cancer
      • +5 more
      • Little Rock, Arkansas
      • +7 more
      Dec 19, 2022

      Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

      Not yet recruiting
      • Non Muscle Invasive Bladder Cancer
      • +3 more
      • Cretostimogene Grenadenorepvec
      • n-dodecyl-B-D-maltoside
      • (no location specified)
      Oct 30, 2023

      Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)

      Recruiting
      • Bladder Cancer
      • 89Zr-TLX250 PET/CT
      • Saint Herblain, France
        Institut de cancerologie de l'Ouest
      Nov 24, 2021

      Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and

      Recruiting
      • Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
      • TLD-1433 Bladder infusion and Photodynamic Therapy
      • Bala-Cynwyd, Pennsylvania
      • +10 more
      May 6, 2022